Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weihan Zhang

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Plos Pathogens|June 17, 2024
Dissecting positive selection events and immunological drives during the evolution of adeno-associated virus lineagesLirong Li, Runkuan Qin, Yunbo Liu, et al.
Oncotarget|September 9, 2017
Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplificationYongxin Ren, Jianming Zheng, Shiming Fan, et al.
ACS Medicinal Chemistry Letters|March 19, 2025
Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer TreatmentKun Xiao, Zheng Zhang, Yao Wu, et al.
ACS Nano|March 19, 2025
Temperature-Sensitive Nano-GOx Combined with Downregulation of Tumor Stemness to Initiate Robust Antitumor EfficacyPanpan Gu, Jinhu Liu, Tong Gao, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2021
Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid CancerLingyun Zhang, Zhixiang Ren, Zhengzheng Su, et al.
Cancer Biology & Therapy|December 9, 2014
Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapyQiaoling Sun, Jinghong Zhou, Zheng Zhang, et al.
Cell Research|August 19, 2017
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stagesChun-Xiao Song, Senlin Yin, Li Ma, et al.
BMJ Open|December 3, 2025
Laparoscopic versus open distal gastrectomy with D2 lymphadenectomy following neoadjuvant chemotherapy for locally advanced gastric cancer (CLASS-03b): protocol for a multicentre, randomised, controlled, non-inferiority trialYidi Liang, Xiaolong Chen, Weihan Zhang, et al.
Science Advances|July 29, 2021
Characterizing dedifferentiation of thyroid cancer by integrated analysisHan Luo, Xuyang Xia, Gyeong Dae Kim, et al.
Cell Reports|October 19, 2022
Dissecting the genetic and microenvironmental factors of gastric tumorigenesis in miceZhenghao Lu, Ailing Zhong, Hongyu Liu, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Plos Pathogens|June 17, 2024
Dissecting positive selection events and immunological drives during the evolution of adeno-associated virus lineagesLirong Li, Runkuan Qin, Yunbo Liu, et al.
Oncotarget|September 9, 2017
Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplificationYongxin Ren, Jianming Zheng, Shiming Fan, et al.
ACS Medicinal Chemistry Letters|March 19, 2025
Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer TreatmentKun Xiao, Zheng Zhang, Yao Wu, et al.
ACS Nano|March 19, 2025
Temperature-Sensitive Nano-GOx Combined with Downregulation of Tumor Stemness to Initiate Robust Antitumor EfficacyPanpan Gu, Jinhu Liu, Tong Gao, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2021
Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid CancerLingyun Zhang, Zhixiang Ren, Zhengzheng Su, et al.
Cancer Biology & Therapy|December 9, 2014
Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapyQiaoling Sun, Jinghong Zhou, Zheng Zhang, et al.
Cell Research|August 19, 2017
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stagesChun-Xiao Song, Senlin Yin, Li Ma, et al.
BMJ Open|December 3, 2025
Laparoscopic versus open distal gastrectomy with D2 lymphadenectomy following neoadjuvant chemotherapy for locally advanced gastric cancer (CLASS-03b): protocol for a multicentre, randomised, controlled, non-inferiority trialYidi Liang, Xiaolong Chen, Weihan Zhang, et al.
Science Advances|July 29, 2021
Characterizing dedifferentiation of thyroid cancer by integrated analysisHan Luo, Xuyang Xia, Gyeong Dae Kim, et al.
Cell Reports|October 19, 2022
Dissecting the genetic and microenvironmental factors of gastric tumorigenesis in miceZhenghao Lu, Ailing Zhong, Hongyu Liu, et al.
Pageof 9